News

All 3 doses of orforglipron superior to placebo with respect to primary end point of change in HbA1c from baseline to week 40.
Novo Nordisk shares have come under pressure amid weight-loss drug competition, while UK health officials have launched a ...
Innovent Biologics presents results from DREAMS-1 phase 3 study of mazdutide in Chinese adults with T2D at ADA Scientific Sessions: San Francisco Thursday, June 26, 2025, 14:00 Hr ...
BrightGene Pharmaceutical Co., Ltd., an international, innovation-driven pharmaceutical company, presented data from two Phase 2 studies for BGM0504, its ...
For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated ...
In 1970, someone over the age of 65 hospitalized for a heart attack in the United States had about a 60% chance of leaving ...
American Diabetes Month - November 2022 – Every November, people can reach out to various healthcare organizations to learn more about how to prevent and manage diabetes. The Association of Diabetes ...
A study finds that inhaled insulin is as effective as traditional injections for children with type 1 diabetes during ...
To address this, researchers tested a new strategy: combining semaglutide (the active ingredient in Ozempic and Wegovy) with an experimental drug called bimagrumab. Bimagrumab is a lab-made antibody ...
Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...
When you stop eating meat, you can experience short-term and long-term effects. Here's what happens to your body.
Children with diabetes who inhaled their mealtime doses of insulin did just as well as those who injected insulin under the ...